Logo image of MAXN

MAXEON SOLAR TECHNOLOGIE (MAXN) Stock Fundamental Analysis

NASDAQ:MAXN - Nasdaq - SGXZ57724486 - Common Stock - Currency: USD

2.79  -0.01 (-0.36%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to MAXN. MAXN was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. MAXN may be in some trouble as it scores bad on both profitability and health. MAXN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MAXN had negative earnings in the past year.
MAXN had a negative operating cash flow in the past year.
In the past 5 years MAXN always reported negative net income.
MAXN had negative operating cash flow in 4 of the past 5 years.
MAXN Yearly Net Income VS EBIT VS OCF VS FCFMAXN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -200M -400M -600M

1.2 Ratios

MAXN has a worse Return On Assets (-175.55%) than 98.18% of its industry peers.
Industry RankSector Rank
ROA -175.55%
ROE N/A
ROIC N/A
ROA(3y)-24.28%
ROA(5y)-21.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MAXN Yearly ROA, ROE, ROICMAXN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 5K 10K 15K 20K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MAXN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MAXN Yearly Profit, Operating, Gross MarginsMAXN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

MAXN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MAXN has been reduced compared to 1 year ago.
The number of shares outstanding for MAXN has been reduced compared to 5 years ago.
MAXN has a worse debt/assets ratio than last year.
MAXN Yearly Shares OutstandingMAXN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
MAXN Yearly Total Debt VS Total AssetsMAXN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

MAXN has an Altman-Z score of -5.71. This is a bad value and indicates that MAXN is not financially healthy and even has some risk of bankruptcy.
MAXN has a worse Altman-Z score (-5.71) than 82.73% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.71
ROIC/WACCN/A
WACC6.73%
MAXN Yearly LT Debt VS Equity VS FCFMAXN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 200M -200M 400M

2.3 Liquidity

MAXN has a Current Ratio of 1.11. This is a normal value and indicates that MAXN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.11, MAXN is doing worse than 90.00% of the companies in the same industry.
MAXN has a Quick Ratio of 1.11. This is a bad value and indicates that MAXN is not financially healthy enough and could expect problems in meeting its short term obligations.
MAXN's Quick ratio of 0.48 is on the low side compared to the rest of the industry. MAXN is outperformed by 94.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.48
MAXN Yearly Current Assets VS Current LiabilitesMAXN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

MAXN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.56%.
MAXN shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.34%.
The Revenue has been decreasing by -4.00% on average over the past years.
EPS 1Y (TTM)-1.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.85%
Revenue 1Y (TTM)35.34%
Revenue growth 3Y-4%
Revenue growth 5YN/A
Sales Q2Q%-73.96%

3.2 Future

Based on estimates for the next years, MAXN will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.92% on average per year.
MAXN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.19% yearly.
EPS Next Y45.88%
EPS Next 2Y41.41%
EPS Next 3Y25.99%
EPS Next 5Y18.92%
Revenue Next Year7.65%
Revenue Next 2Y-21.63%
Revenue Next 3Y-6.13%
Revenue Next 5Y0.19%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MAXN Yearly Revenue VS EstimatesMAXN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
MAXN Yearly EPS VS EstimatesMAXN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -200 -400 -600

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MAXN. In the last year negative earnings were reported.
Also next year MAXN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAXN Price Earnings VS Forward Price EarningsMAXN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MAXN Per share dataMAXN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600

4.3 Compensation for Growth

MAXN's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.41%
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

MAXN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAXEON SOLAR TECHNOLOGIE

NASDAQ:MAXN (5/6/2025, 8:22:35 PM)

2.79

-0.01 (-0.36%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)N/A N/A
Inst Owners5.45%
Inst Owner Change-2.21%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap42.46M
Analysts45
Price Target57.25 (1951.97%)
Short Float %13.19%
Short Ratio2.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)34.95%
Min EPS beat(2)-12.21%
Max EPS beat(2)82.1%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-6.76%
Min Revenue beat(2)-15.54%
Max Revenue beat(2)2.03%
Revenue beat(4)1
Avg Revenue beat(4)-5.9%
Min Revenue beat(4)-15.54%
Max Revenue beat(4)2.03%
Revenue beat(8)2
Avg Revenue beat(8)-4.76%
Revenue beat(12)4
Avg Revenue beat(12)-2.93%
Revenue beat(16)5
Avg Revenue beat(16)-2.78%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-653
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-26.23
FCFYN/A
OCF(TTM)-22.31
OCFYN/A
SpS57.59
BVpS-13.87
TBVpS-13.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -175.55%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-24.28%
ROA(5y)-21.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.99
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 120.75%
Cap/Sales 6.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 0.48
Altman-Z -5.71
F-Score2
WACC6.73%
ROIC/WACCN/A
Cap/Depr(3y)199.78%
Cap/Depr(5y)147.34%
Cap/Sales(3y)10.57%
Cap/Sales(5y)7.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.85%
EPS Next Y45.88%
EPS Next 2Y41.41%
EPS Next 3Y25.99%
EPS Next 5Y18.92%
Revenue 1Y (TTM)35.34%
Revenue growth 3Y-4%
Revenue growth 5YN/A
Sales Q2Q%-73.96%
Revenue Next Year7.65%
Revenue Next 2Y-21.63%
Revenue Next 3Y-6.13%
Revenue Next 5Y0.19%
EBIT growth 1Y-1190.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-15.49%
EBIT Next 3Y35.95%
EBIT Next 5YN/A
FCF growth 1Y-275.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2575.5%
OCF growth 3YN/A
OCF growth 5YN/A